Skip to main content
. Author manuscript; available in PMC: 2023 Jan 5.
Published in final edited form as: Cancer Prev Res (Phila). 2022 Jul 5;15(7):447–454. doi: 10.1158/1940-6207.CAPR-22-0011

Table 1.

Baseline characteristics of 12,609 genotyped participants according to PRS group.

Characteristic Low PRS(q1), No. (%) Medium PRS (q2-q4), No. (%) High PRS (q5), No. (%)
No. of participants 2522 7565 2522
PRS, mean (SD) 7.24 (0.21) 7.86 (0.21) 8.49 (0.22)
Family history of colorectal cancer 311 (12.3) 1156 (15.3) 458 (18.2)
Sex, female 1395 (55.3) 4147 (54.8) 1391 (55.2)
Age at randomisation, years, mean (SD) 74.9 (4.1) 75.1 (4.2) 75.0 (4.2)
 70–74 years 1562 (61.9) 4563 (60.3) 1534 (60.8)
 75–79 years 631 (25.0) 1916 (25.3) 633 (25.1)
 80–84 years 261 (10.3) 844 (11.2) 268 (10.6)
 85+ years 68 (2.7) 242 (3.2) 87 (3.4)
Smoker - ever 1131 (44.8) 3301 (43.6) 1135 (45.0)
Current alcohol consumption 2028 (80.4) 6031 (79.7) 1994 (79.1)
History of diabetes 223 (8.8) 696 (9.2) 248 (9.8)
Mean body mass index (SD), kg/m2 28.1 (4.5) 28.0 (4.6) 28.0 (4.5)
Randomized to aspirin 1276 (50.6) 3768 (49.8) 1244 (49.3)

Note: Brackets are for % of the population in that PRS group unless specified.